Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harish Rao

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Vaccines|June 27, 2024
A Combined LC-MS and Immunoassay Approach to Characterize Preservative-Induced Destabilization of Human Papillomavirus Virus-like Particles Adsorbed to an Aluminum-Salt AdjuvantRia T Caringal, John M Hickey, Nitya Sharma, et al.
Frontiers in Immunology|June 21, 2023
Multiplexed bead-based assay for the simultaneous quantification of human serum IgG antibodies to tetanus, diphtheria, pertussis toxin, filamentous hemagglutinin, and pertactinVishal Rathod, Laxmikant Kadam, Manish Gautam, et al.
Vaccines|October 28, 2023
Large-Scale Purification and Characterization of Recombinant Receptor-Binding Domain (RBD) of SARS-CoV-2 Spike Protein Expressed in YeastGaurav Nagar, Siddharth Jain, Meghraj Rajurkar, et al.
Journal of Pharmaceutical Sciences|December 3, 2022
Multi-dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part II- Real-time and Accelerated Stability StudiesNitya Sharma, Kaushal Jerajani, Ying Wan, et al.
Frontiers in Immunology|July 16, 2025
Quantitative bead-based multiplex assay for simultaneous determination of IgG concentrations of pertussis toxin, filamentous hemagglutinin, pertactin, diphtheria, tetanus, Haemophilus influenzae b, and hepatitis B in human serum samplesVishal Rathod, Sagar Katke, Sumant Patil, et al.
Journal of Pharmaceutical Sciences|September 12, 2022
Multi-Dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part I - Screening of Preservative CombinationsKaushal Jerajani, Ying Wan, Ozan S Kumru, et al.
Journal of Pharmaceutical Sciences|August 1, 2022
Analytical and Preformulation Characterization Studies of Human Papillomavirus Virus-Like Particles to Enable Quadrivalent Multi-Dose Vaccine Formulation DevelopmentKaushal Jerajani, Ying Wan, John M Hickey, et al.
Expert Review of Vaccines|March 8, 2023
Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in IndiaHitt J Sharma, Sameer Parekh, Pramod Pujari, et al.
The Lancet. Oncology|November 10, 2023
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trialHitt Sharma, Sameer Parekh, Pramod Pujari, et al.
Psychiatric Genetics|March 27, 2014
Evidence for genetic susceptibility to the alcohol dependence syndrome from the thiamine transporter 2 gene solute carrier SLC19A3Giorgia Quadri, Andrew McQuillin, Irene Guerrini, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Vaccines|June 27, 2024
A Combined LC-MS and Immunoassay Approach to Characterize Preservative-Induced Destabilization of Human Papillomavirus Virus-like Particles Adsorbed to an Aluminum-Salt AdjuvantRia T Caringal, John M Hickey, Nitya Sharma, et al.
Frontiers in Immunology|June 21, 2023
Multiplexed bead-based assay for the simultaneous quantification of human serum IgG antibodies to tetanus, diphtheria, pertussis toxin, filamentous hemagglutinin, and pertactinVishal Rathod, Laxmikant Kadam, Manish Gautam, et al.
Vaccines|October 28, 2023
Large-Scale Purification and Characterization of Recombinant Receptor-Binding Domain (RBD) of SARS-CoV-2 Spike Protein Expressed in YeastGaurav Nagar, Siddharth Jain, Meghraj Rajurkar, et al.
Journal of Pharmaceutical Sciences|December 3, 2022
Multi-dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part II- Real-time and Accelerated Stability StudiesNitya Sharma, Kaushal Jerajani, Ying Wan, et al.
Frontiers in Immunology|July 16, 2025
Quantitative bead-based multiplex assay for simultaneous determination of IgG concentrations of pertussis toxin, filamentous hemagglutinin, pertactin, diphtheria, tetanus, Haemophilus influenzae b, and hepatitis B in human serum samplesVishal Rathod, Sagar Katke, Sumant Patil, et al.
Journal of Pharmaceutical Sciences|September 12, 2022
Multi-Dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part I - Screening of Preservative CombinationsKaushal Jerajani, Ying Wan, Ozan S Kumru, et al.
Journal of Pharmaceutical Sciences|August 1, 2022
Analytical and Preformulation Characterization Studies of Human Papillomavirus Virus-Like Particles to Enable Quadrivalent Multi-Dose Vaccine Formulation DevelopmentKaushal Jerajani, Ying Wan, John M Hickey, et al.
Expert Review of Vaccines|March 8, 2023
Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in IndiaHitt J Sharma, Sameer Parekh, Pramod Pujari, et al.
The Lancet. Oncology|November 10, 2023
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trialHitt Sharma, Sameer Parekh, Pramod Pujari, et al.
Psychiatric Genetics|March 27, 2014
Evidence for genetic susceptibility to the alcohol dependence syndrome from the thiamine transporter 2 gene solute carrier SLC19A3Giorgia Quadri, Andrew McQuillin, Irene Guerrini, et al.
Pageof 5